Journal of Immunotherapy

SJR Rank #4,255H-index: 111SJR: 1.088Best quartile: Q1
Journal website: aims, scope and author guidelines
Publisher

Lippincott Williams and Wilkins

Country

United States

Type

journal

SJR by Edition

2022202500.350.71.051.4

Subject Categories

  • PharmacologyQ1
  • Cancer ResearchQ2
  • ImmunologyQ2
  • Immunology and AllergyQ2

Areas: Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Immunotherapy and Immune ResponsesCAR-T cell therapy researchCancer Immunotherapy and BiomarkersImmune Cell Function and InteractionMonoclonal and Polyclonal Antibodies ResearchT-cell and B-cell ImmunologyVirus-based gene therapy researchRNA Interference and Gene Deliveryvaccines and immunoinformatics approachesCancer Research and Treatments

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs04080120160

Documents per Year

20222025015304560

Detailed Information

ISSN

1524-9557, 1537-4513

SJR Best Quartile

Q1

Region

Northern America

Citations per Document (2 years)

2.75

References per Document

38.67

Coverage

1991-2026

Scope

Journal of Immunotherapy features rapid publication of articles on immunomodulators, lymphokines, antibodies, cells, and cell products in cancer biology and therapy. Laboratory and preclinical studies, as well as investigative clinical reports, are presented. The journal emphasizes basic mechanisms and methods for the rapid transfer of technology from the laboratory to the clinic. JIT contains full-length articles, review articles, and short communications.

Metrics from SCImago Journal Rank 2025. View on SCImago